Daisuke Nakada

Daisuke Nakada

Auto-generated profile, based on publicly available information

Daisuke Nakada

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2020 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
HLHyemin Lee
Hyemin Lee
FZFereshteh Zandkarimi
Fereshteh Zandkarimi
YZYilei Zhang
Yilei Zhang
JMJitendra Kumar Meena
Jitendra Kumar Meena
JKJongchan Kim
Jongchan Kim
BGBoyi Gan
Boyi Gan

1 November 2009 in Annual Review of Cell and Developmental Biology
Verified
Journal Article
Closed access
HSHe Shenghui
He Shenghui
DNDaisuke Nakada
Daisuke Nakada
SMSean J. Morrison
Sean J. Morrison
Self-renewal is the process by which stem cells divide to make more stem cells, perpetuating the stem cell pool throughout life. Self-renewal is division with maintenance of the undifferentiated state. This requires cell cycle control and often maintenance of multipotency or pluripotency, depending on the stem cell. Self-renewal programs involve networks that balance proto-oncogenes (promoting self-renewal), gate-keeping tumor suppressors (limiting self-renewal), and care-taking tumor suppressors (maintaining genomic integrity). These cell-intrinsic mechanisms are regulated by cell-extrinsic signals from the niche, the microenvironment that maintains stem cells and regulates their function in tissues. In response to changing tissue demands, stem cells undergo changes in cell cycle status and developmental potential over time, requiring different self-renewal programs at different stages of life. Reduced stem cell function and tissue regenerative capacity during aging are caused by changes in self-renewal programs that augment tumor suppression. Cancer arises from mutations that inappropriately activate self-renewal programs.

1 December 2010 in Nature
Verified
Journal Article
Open access
PDF file
DNDaisuke Nakada
Daisuke Nakada
TSThom Saunders
Thom Saunders
SMSean J. Morrison
Sean J. Morrison
Little is known about metabolic regulation in stem cells and how this modulates tissue regeneration or tumour suppression. We studied the Lkb1 tumour suppressor and its substrate AMP-activated protein kinase (AMPK), kinases that coordinate metabolism with cell growth. Deletion of the Lkb1 (also called Stk11) gene in mice caused increased haematopoietic stem cell (HSC) division, rapid HSC depletion and pancytopenia. HSCs depended more acutely on Lkb1 for cell-cycle regulation and survival than many other haematopoietic cells. HSC depletion did not depend on mTOR activation or oxidative stress. Lkb1-deficient HSCs, but not myeloid progenitors, had reduced mitochondrial membrane potential and ATP levels. HSCs deficient for two catalytic α-subunits of AMPK (AMPK-deficient HSCs) showed similar changes in mitochondrial function but remained able to reconstitute irradiated mice. Lkb1-deficient HSCs, but not AMPK-deficient HSCs, exhibited defects in centrosomes and mitotic spindles in culture, and became aneuploid. Lkb1 is therefore required for HSC maintenance through AMPK-dependent and AMPK-independent mechanisms, revealing differences in metabolic and cell-cycle regulation between HSCs and some other haematopoietic progenitors.

21 October 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
KMKiyomi Morita
Kiyomi Morita
FWFeng Wang
Feng Wang
KJKatharina Jahn
Katharina Jahn
THTianyuan Hu
Tianyuan Hu
TTTomoyuki Tanaka
Tomoyuki Tanaka
KTKoichi Takahashi
Koichi Takahashi
Clonal diversity is a consequence of cancer cell evolution driven by Darwinian selection. Precise characterization of clonal architecture is essential to understand the evolutionary history of tumor development and its association with treatment resistance. Here, using a single-cell DNA sequencing, we report the clonal architecture and mutational histories of 123 acute myeloid leukemia (AML) patients. The single-cell data reveals cell-level mutation co-occurrence and enables reconstruction of mutational histories characterized by linear and branching patterns of clonal evolution, with the latter including convergent evolution. Through xenotransplantion, we show leukemia initiating capabilities of individual subclones evolving in parallel. Also, by simultaneous single-cell DNA and cell surface protein analysis, we illustrate both genetic and phenotypic evolution in AML. Lastly, single-cell analysis of longitudinal samples reveals underlying evolutionary process of therapeutic resistance. Together, these data unravel clonal diversity and evolution patterns of AML, and highlight their clinical relevance in the era of precision medicine.

22 January 2014 in Nature
Verified
Journal Article
Open access
PDF file
DNDaisuke Nakada
Daisuke Nakada
HOHideyuki Oguro
Hideyuki Oguro
BLBoaz P. Levi
Boaz P. Levi
NRNicole Ryan
Nicole Ryan
AKAyumi Kitano
Ayumi Kitano
SMSean J. Morrison
Sean J. Morrison
Haematopoietic stem cells are found to be regulated differently in male and female mice — haematopoietic stem cells in females divide more frequently than in males in response to oestrogen and this difference depends on the ovaries but not the testes; using a genetic approach, it is shown that the effect is dependent on expression of oestrogen receptor-α (ERα) in stem cells. The extent to which stem cells are regulated by long-range signals versus local signals within tissues is a fundamental question in stem-cell biology. Much recent research has focused on how the stem-cell niche responds to local signals within tissues. But in conditions such as starvation or pregnancy it is likely that systemic signals will modulate stem-cell function in multiple tissues, and this study demonstrates a long-range effect of oestrogen on haematopoietic stem cells (HSCs) in pregnant mice. Using a genetic approach, the authors show that HSC stimulation, which would help the mother to meet increased haematopoietic demands, is dependent on expression of the oestrogen receptor (ERα). Hormonal levels differ in males and females but so too do the HSC cells — stem cells in female mice divide significantly more frequently than those in male mice in response to oestrogen. Sexually dimorphic mammalian tissues, including sexual organs and the brain, contain stem cells that are directly or indirectly regulated by sex hormones1,2,3,4,5,6. An important question is whether stem cells also exhibit sex differences in physiological function and hormonal regulation in tissues that do not show sex-specific morphological differences. The terminal differentiation and function of some haematopoietic cells are regulated by sex hormones7,8,9,10, but haematopoietic stem-cell function is thought to be similar in both sexes. Here we show that mouse haematopoietic stem cells exhibit sex differences in cell-cycle regulation by oestrogen. Haematopoietic stem cells in female mice divide significantly more frequently than in male mice. This difference depends on the ovaries but not the testes. Administration of oestradiol, a hormone produced mainly in the ovaries, increased haematopoietic stem-cell division in males and females. Oestrogen levels increased during pregnancy, increasing haematopoietic stem-cell division, haematopoietic stem-cell frequency, cellularity, and erythropoiesis in the spleen. Haematopoietic stem cells expressed high levels of oestrogen receptor-α (ERα). Conditional deletion of ERα from haematopoietic stem cells reduced haematopoietic stem-cell division in female, but not male, mice and attenuated the increases in haematopoietic stem-cell division, haematopoietic stem-cell frequency, and erythropoiesis during pregnancy. Oestrogen/ERα signalling promotes haematopoietic stem-cell self-renewal, expanding splenic haematopoietic stem cells and erythropoiesis during pregnancy.

1 October 2016 in Cell Reports
Verified
Journal Article
Open access
MGMichael C. Gundry
Michael C. Gundry
LBLorenzo Brunetti
Lorenzo Brunetti
ALAngelique Lin
Angelique Lin
AMAllison E. Mayle
Allison E. Mayle
AKAyumi Kitano
Ayumi Kitano
DNDaisuke Nakada
Daisuke Nakada
Our understanding of the mechanisms that regulate hematopoietic stem/progenitor cells (HSPCs) has been advanced by the ability to genetically manipulate mice; however, germline modification is time consuming and expensive. Here, we describe fast, efficient, and cost-effective methods to directly modify the genomes of mouse and human HSPCs using the CRISPR/Cas9 system. Using plasmid and virus-free delivery of guide RNAs alone into Cas9-expressing HSPCs or Cas9-guide RNA ribonucleoprotein (RNP) complexes into wild-type cells, we have achieved extremely efficient gene disruption in primary HSPCs from mouse (>60%) and human (∼75%). These techniques enabled rapid evaluation of the functional effects of gene loss of Eed, Suz12, and DNMT3A. We also achieved homology-directed repair in primary human HSPCs (>20%). These methods will significantly expand applications for CRISPR/Cas9 technologies for studying normal and malignant hematopoiesis.